Literature DB >> 8843216

Differential activation of extracellular signal-regulated kinase (ERK) 1, ERK2, p38, and c-Jun NH2-terminal kinase mitogen-activated protein kinases by bacterial peptidoglycan.

R Dziarski1, Y P Jin, D Gupta.   

Abstract

Soluble staphylococcal peptidoglycan (sPGN) is an inducer of cytokine secretion and may activate macrophages through the CD14 lipopolysaccharide (LPS) receptor. To elucidate sPGN-activated signal transduction pathways, stimulation of mitogen-activated protein (MAP) kinases by sPGN was studied in mouse RAW264.7 macrophages. sPGN strongly activated extracellular signal-regulated kinase (ERK) 1 and ERK2, moderately activated c-Jun NH2 terminal kinase (JNK), and weakly activated p38 MAP kinase, in contrast to LPS, which strongly activated all of these kinases, and phorbol 12,13-dibutyrate (PDB), which strongly activated ERK1 and ERK2 but did not activate p38 or JNK. sPGN- and LPS-induced activation of ERK1 and ERK2, unlike PDB-induced activation, was sensitive to inhibition by herbimycin A and insensitive to inhibition by increased intracellular cAMP. These results demonstrate differential activation of MAP kinases by sPGN, similar but not identical activation of signal transduction pathways by sPGN and LPS, and different mechanisms of MAP kinase activation by bacterial stimulants and phorbol esters.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8843216     DOI: 10.1093/infdis/174.4.777

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  22 in total

1.  Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF-alpha) translation: glucocorticoids inhibit TNF-alpha translation by blocking JNK/SAPK.

Authors:  J L Swantek; M H Cobb; T D Geppert
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

2.  Peptidoglycan and lipoteichoic acid modify monocyte phenotype in human whole blood.

Authors:  P F Jørgensen; J E Wang; M Almlöf; C Thiemermann; S J Foster; R Solberg; A O Aasen
Journal:  Clin Diagn Lab Immunol       Date:  2001-05

Review 3.  Toll-like receptors in defense and damage of the central nervous system.

Authors:  Rajagopal N Aravalli; Phillip K Peterson; James R Lokensgard
Journal:  J Neuroimmune Pharmacol       Date:  2007-04-03       Impact factor: 4.147

4.  Specific binding of soluble peptidoglycan and muramyldipeptide to CD14 on human monocytes.

Authors:  B Weidemann; J Schletter; R Dziarski; S Kusumoto; F Stelter; E T Rietschel; H D Flad; A J Ulmer
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

5.  Gram-positive and gram-negative bacteria do not trigger monocytic cytokine production through similar intracellular pathways.

Authors:  L Rabehi; T Irinopoulou; B Cholley; N Haeffner-Cavaillon; M P Carreno
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

6.  Defective IL-12 production in mitogen-activated protein (MAP) kinase kinase 3 (Mkk3)-deficient mice.

Authors:  H T Lu; D D Yang; M Wysk; E Gatti; I Mellman; R J Davis; R A Flavell
Journal:  EMBO J       Date:  1999-04-01       Impact factor: 11.598

7.  Effects of downregulation of aquaporin1 by peptidoglycan and lipopolysaccharide via MAPK pathways in MeT-5A cells.

Authors:  Lihua Liu; Canmao Xie
Journal:  Lung       Date:  2011-06-04       Impact factor: 2.584

8.  A novel mitogen-activated protein kinase phosphatase is an important negative regulator of lipopolysaccharide-mediated c-Jun N-terminal kinase activation in mouse macrophage cell lines.

Authors:  T Matsuguchi; T Musikacharoen; T R Johnson; A S Kraft; Y Yoshikai
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

Review 9.  Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock.

Authors:  Edwin S Van Amersfoort; Theo J C Van Berkel; Johan Kuiper
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

10.  Antagonistic antibody prevents toll-like receptor 2-driven lethal shock-like syndromes.

Authors:  Guangxun Meng; Mark Rutz; Matthias Schiemann; Jochen Metzger; Alina Grabiec; Ralf Schwandner; Peter B Luppa; Frank Ebel; Dirk H Busch; Stefan Bauer; Hermann Wagner; Carsten J Kirschning
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.